Communication from Cigna International concerning COVID19

Cigna announced today:

  • the further extension of expanded coverage and,
  • waiving cost share and deductibles for COVID19 in-network treatment.

COVID19COVID19 testing and treatment

« If not available locally free-of-charge as part of local government health systems, Cigna will cover in-network

  • medically necessary testing for COVID-19 and,
  • related doctor visits on an outpatient basis.

We are pleased to confirm we are extending this until 31st January 2021.

PCR testing and rapid antigen testing for Covid-19 are covered in line with the plan’s coverage for diagnostics for other illnesses and for:

  • symptomatic individuals if medically necessary per WHO or national guidelines i.e. when experiencing symptoms such as a new cough, fever and change in smell or taste; or
  • asymptomatic individuals who know, or suspect, that they have been exposed to an individual with a laboratory confirmed case of COVID-19; or
  • asymptomatic individuals who are being admitted to hospital for any treatment, and Covid-19 testing is required as part of the hospital’s standard disease control and prevention admission process.

COVID19When is testing not covered?

Cigna will not cover Covid-19 related diagnostics for:

  • serology antibody testing,
  • home testing kits,
  • Over-the-Counter (OTC) tests,
  • testing for population or public health screening including but not limited to, the following:
    1. determine prevalence of COVID-19 infection in the community or congregate setting,
    2. return-to-work,
    3. return-to-school,
    4. participation in sports,
    5. routine and/or executive physicals,
    6. travel.

COVID19Extension of COVID19 Support

We will also continue to waive cost share and deductibles for all COVID19 in-network treatment:

  • if you are diagnosed with COVID19,
  • until 31st January 2021.

These continued measures underpin our dedication to protect you from unexpected costs. And to deliver access to quality healthcare.